Tom studied at the University of Oxford before completing his PhD at the University of Cambridge in the epigenetics of ageing.
Robin graduated from the University of Manchester before working for some of the biggest names in tech and advertising including Saatchi & Saatchi where he was Head of Development.
Daniel has great expertise in computational epigenetics, acquired during his PhD in the European Bioinformatics Institute.
Head of Operations
Sana is an economist by background, and has spent 7 years consulting in operations and technology for FTSE 100 organisations and start-ups across 4 continents.
Jose obtained his MsC in Computer Science from the University of Málaga, where he also undertook a PhD in Software Engineering and Artificial Intelligence.
Charles has extensive marketing and sales experience and previously led operations in the high end services and real estate industries.
Bobby Banks is a Senior Advisor to Chronomics. Bobby is a seasoned financial services executive with senior level positions at Goldman Sachs and JP Morgan.
Ann has held senior board roles for a wide range of global B2B and consumer brands including heading up all European and International operation for NordicTrack a USA fitness company.
Toby studied at the University of Oxford before completing a PhD in industrial biotechnology at the University of Cambridge.
Edwin has worked for a number of high growth start-ups and accelerators including Bethnal Green Ventures and Founders Factory - launching products across Health and Education as well as launching two successful mobile games on the App store. He is passionate about solving problems through design to create positive change.
Jason has worked with some of the world's leading companies including Ebay, Just Eat, LGT Bank, Yellow Pages and many more.
Diljeet is conducting his PhD at the University of Cambridge, working on the potential of stem cells to reverse epigenetic ageing. At Chronomics, Diljeet is responsible for bringing epigenetic phenomena to the world stage.
Prof. Thornton is a Fellow of the Royal Society, a Fellow of the Academy of Medical Sciences, a member of EMBO and a foreign associate of the US National Academy of Sciences.
Prof. Vineis latest research focuses on biomarkers of disease risk, complex exposures and intermediate biomarkers from omic platforms (including epigenetics) in large epidemiological studies.
Prof. Reik obtained his MD from the University of Hamburg, and was an EMBO and Lister Institute Fellow in Cambridge, before becoming Head of the Epigenetics Programme and Associate Director at the Babraham Institute.